Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1986-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.83.19.7443PMID 3463976PMCID PMC386734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of auto-anti-idiotypic antibody during the normal immune response. XII. Enhanced auto-anti-idiotypic antibody production as a mechanism for apparent B-cell tolerance in rabbits after feeding antigen.

  1986cited by this paper
• Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity.

  1985cited by this paper
• Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule

  1985cited by this paper
• Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell.

  1985cited by this paper
• Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci

  1985cited by this paper
• Type II collagen-reactive T cell clones from mice with collagen-induced arthritis.

  1985cited by this paper
• Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen.

  1984cited by this paper
• Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cells.

  1984cited by this paper
• Collagen-induced and adjuvant-induced arthritis in rats. Post-immunization treatment with collagen to suppress or abrogate the arthritic response.

  1984cited by this paper
• Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen.

  1983cited by this paper
• Serum transfer of collagen-induced arthritis in mice

  1983cited by this paper
• Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin.

  1983cited by this paper
• Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats.

  1983cited by this paper
• Abrogation by subsequent feeding of antibody response including IgE, in parenterally immunized mice

  1982cited by this paper
• Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells.

  1982cited by this paper
• Preparation and characterization of the different types of collagen.

  1982cited by this paper
• Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding.

  1981cited by this paper
• Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

  1981cited by this paper
• Oral-parenteral immunization leads to the appearance of IgG auto-anti-idiotypic cells in mucosal tissues.

  1981cited by this paper
• Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man.

  1981cited by this paper
• Orally induced tolerance. Definition at the cellular level.

  1981cited by this paper
• Immunisation against heterologous type II collagen induces arthritis in mice

  1980cited by this paper
• Systemic tolerance and secretory immunity after oral immunization

  1980cited by this paper
• Oral tolerance.

  1980cited by this paper
• Absorption of antigens after oral immunisation and the simultaneous induction of specific systemic tolerance.

  1979cited by this paper
• Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.

  1979cited by this paper
• Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin.

  1978cited by this paper
• Enterically induced immunologic tolerance. I. Induction of suppressor T lymphoyctes by intragastric administration of soluble proteins.

  1978cited by this paper
• Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.

  1978cited by this paper
• Autoimmunity to type II collagen an experimental model of arthritis

  1977cited by this paper
• Assessing B cell diversification by antigen receptor and precursor cell analysis.

  1976cited by this paper
• H‐2‐linked genetic control of antibody response to soluble calf skin collagen in mice

  1975cited by this paper
• Specificity of the antibody response in inbred mice to bovine type I and type II collagen.

  1975cited by this paper
• The induction of tolerance to a soluble protein antigen by oral administration.

  1974cited by this paper
• Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

  1972cited by this paper
• Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats.

  1969cited by this paper
• ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS

  1964cited by this paper
• Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent

  1946cited by this paper

• AAV Gene Therapy for MPS IVA with Induction of Immune Tolerance via Oral Administration of Epitope Peptides of N-Acetylgalactosamine-6-sulfate Sulfatase

  2026cites this paper
• The concentration-, pH- and temperature-responsive self-assembly of undenatured type II collagen: kinetics, thermodynamics, nanostructure and molecular mechanism

  2025cites this paper
• Proposal for Diet Supplementation to Prevent Knee Osteoarthritis in Female Soccer Players

  2025cites this paper
• Gut mucosal immune responses - Implications for celiac disease and food allergy.

  2025cites this paper
• Undenatured type II collagen nanofibrils with sodium alginate coating: Structural characterization, physicochemical properties and capability to load curcumin.

  2024cites this paper
• Fibroblast-like synoviocytes orchestrate daily rhythmic inflammation in arthritis

  2024cites this paper
• Metabolomics Reveals Disturbed Amino Acid Metabolism During Different Stages of RA in Collagen-Induced Arthritis Mice

  2024cites this paper
• Immune responses to food

  2024cites this paper
• NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells

  2024cites this paper
• Optimizing Oral Immune Tolerance to Type II Collagen in Patients with Rheumatoid Arthritis: The Importance of Dose, Interfering Medication and Genetics.

  2024cites this paper
• All roads lead to IgA: Mapping the many pathways of IgA induction in the gut

  2024cites this paper
• Role of undenatured type II collagen in novel ternary interpenetrating polymer networks hydrogel based on structural modulation and properties characterization

  2024cites this paper
• Ternary complex of soluble undenatured type II collagen-hydrophobic phytochemical-chondroitin sulfate facilitates high stability and targeted intestinal release properties to active substance.

  2024cites this paper
• Evaluation of the Effects of an Undenatured Collagen Type-2-Based Nutraceutical (ARTHROSHINE® HA²) on Recovery Time after TPLO in Dogs: A Prospective, Randomized Study with Objective Gait Analysis as the Primary Outcome Measure

  2024cites this paper
• Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D3 in knee osteoarthritis: a resolution of the Expert panel

  2024cites this paper
• Oral tolerance to dietary antigens and Foxp3+ regulatory T cells

  2024cites this paper
• The concentration-, pH- and temperature-responsive self-assembly of undenatured type II collagen: Kinetics, thermodynamics, nanostructure and molecular mechanism

  2023cites this paper
• Immune-based, multifaceted inactivation of pathogenic T lymphocytes in treating autoimmune diseases

  2023cites this paper
• High gastrointestinal digestive stability endows chondroitin sulfate-soluble undenatured type II collagen complex with high activity: Improvement of osteoarthritis in rats.

  2023cites this paper
• The efficacy and safety of low-molecular-weight collagen peptides for joint pain in patients with osteoarthritis: A randomized, double-blind, placebo-controlled study

  2023cites this paper
• Differences between soluble and insoluble undenatured type II collagen in improving osteoarthritis in rats and their potential mechanisms.

  2023cites this paper
• Autoimmunity and autoinflammation — the key to understanding the pathogenesis of osteoarthritis and developing new ways for its prevention and therapy

  2023cites this paper
• Efficacy and Safety of Undenatured Type II Collagen in The Treatment of Osteoarthritis of The Knee: A Randomized, Double-blind, Placebo-controlled Trial

  2023cites this paper
• New therapeutic opportunities in management of patients with joint hypermobility syndrome and synovitis. Clinical example: A review

  2023cites this paper
• Resolution of the Council of Experts “Results of a multicenter, randomized, double-blind, placebo-controlled study of ARTNEO in patients with stage II–III primary knee osteoarthritis”

  2023cites this paper
• Undenatured type II collagen and its role in improving osteoarthritis.

  2023cites this paper
• Collagen Supplementation for Joint Health: The Link between Composition and Scientific Knowledge

  2023cites this paper
• Effects of different mechanical processes on the structural and powdery properties of insoluble undenatured type II collagen.

  2022cites this paper
• Novel ELISA technology in assessing undenatured type II collagen in functional foods and dietary supplements used for knee joint health care: its sensitivity, precision, and accuracy

  2022cites this paper
• Orally administered antigen can reduce or exacerbate pathology in an animal model of inflammatory arthritis dependent upon the timing of administration

  2022cites this paper
• Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies.

  2022cites this paper
• UNDENATURED COLLAGEN TYPE II FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

  2022cites this paper
• Efficacy and Safety of Dietary Undenatured Type II Collagen on Joint and Motor Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.

  2022cites this paper
• Electrostatic interactions with anionic polysaccharides reduced the degradation of pepsin soluble undenatured type II collagen during gastric digestion under pH 2.0

  2022cites this paper
• Functional Characterization of Undenatured Type II Collagen Supplements: Are They Interchangeable?

  2021cites this paper
• Antigen-specific tolerance approach for rheumatoid arthritis: past, present and future.

  2021cites this paper
• Relations entre foie et immunité

  2021cites this paper
• Testing a Novel Peptide-Infused Cream for Treatment of Rheumatoid Arthritis in DR4tg Mice

  2021cites this paper
• Bioprinting of Collagen Type I and II via Aerosol Jet Printing for the Replication of Dense Collagenous Tissues

  2021cites this paper
• Undenatured type II collagen prevents and treats osteoarthritis and motor function degradation in T2DM patients and db/db mice.

  2021cites this paper
• Oral tolerance as antigen-specific immunotherapy

  2021cites this paper
• Preclinical models of arthritis for studying immunotherapy and immune tolerance

  2021cites this paper
• Role of undenatured collagen type ii in management of osteoarthritis: A hospital based study

  2020cites this paper
• Immunotherapy for Autoimmune Diseases

  2020cites this paper
• Undenatured Type II Collagen (UC-II) in Joint Health and Disease: A Review on the Current Knowledge of Companion Animals

  2020cites this paper
• Oral Biosciences: The annual review 2019.

  2020cites this paper
• Protein solubility, secondary structure and microstructure changes in two types of undenatured type II collagen under different gastrointestinal digestion conditions.

  2020cites this paper
• Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy.

  2019cites this paper
• Intestinal Macromolecular Transport Supporting Adaptive Immunity

  2019cites this paper
• Effects of administration of glucosamine and chicken cartilage hydrolysate on rheumatoid arthritis in SKG mice.

  2019cites this paper
• Effect of Oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Mice Model

  2019cites this paper
• Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials

  2018cites this paper
• Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells

  2017cites this paper
• Design strategies for new drugs targeting multicomponent systems : focusing on class II MHC proteins and acetylcholinesterase

  2017cites this paper
• Murine models for mucosal tolerance in allergy.

  2017cites this paper
• Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis

  2017cites this paper
• EXERCISE-NDUCED JOINT PAN IN NON-ARTHRITIC MAMMALS

  2017cites this paper
• Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis

  2016cites this paper
• Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis

  2016cites this paper
• Vitamin A Deficiency Impairs Induction of Oral Tolerance in Mice.

  2015cites this paper
• Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression in Lactococcus lactis.

  2015cites this paper
• Safety and Efficacy of NEXT-II ® , a Novel Water-Soluble, Undenatured Type II Collagen in Healthy Human Subjects Suffering from Occasional Knee Joint Pain

  2015cites this paper
• The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion.

  2015cites this paper
• Mechanisms of Oral Tolerance to Soluble Protein Antigens

  2015cites this paper
• Новые терапевтические возможности контроля гипертонии: современный антагонист рецепторов ангиотензина – Эдарби (азилсартана медоксомил)

  2015cites this paper
• Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study

  2015cites this paper
• Genomics/Proteomics of NEXT‐II®, a Novel Water‐Soluble, Undenatured Type II Collagen in Joint Health Care

  2015cites this paper
• Nutritional Approach for Relief of Joint Discomfort: A 12-week, Open-case Series and Illustrative Case Report.

  2015cites this paper
• Antigen-based immunotherapy for autoimmune disease: current status

  2014cites this paper
• Antigen-based immunotherapy for autoimmune disease : current status

  2014cites this paper
• Metabolic syndrome – Removing roadblocks to therapy: Antigenic immunotherapies☆

  2014cites this paper
• Early upregulation of Socs1 contributes to antigen-specific tolerance in collagen-induced arthritis

  2014cites this paper
• Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case

  2014cites this paper
• Recombinant therapeutic protein vaccines.

  2013cites this paper
• Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers

  2013cites this paper
• DIABETIC STUDIES The Review of Chapter III . 4 Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes

  2013cites this paper
• Self-tolerance in collagen induced arthritis

  2013cites this paper
• Low dose native type II collagen prevents pain in a rat osteoarthritis model

  2013cites this paper
• Characteristics of induced regulatory T cells and bystander suppression

  2013cites this paper
• Suppressing Adjuvant Arthritis and Potentiates Oral Induction of Tolerance, 2-Adrenergic Agonist Salbutamol β The

  2013cites this paper
• Water-Soluble Undenatured Type II Collagen Ameliorates Collagen-Induced Arthritis in Mice

  2013cites this paper
• Trials in type 1 diabetes: Antigen-specific therapies.

  2013cites this paper
• The regulation of allergic airway disease by type V collagen-induced tolerance

  2012cites this paper
• Antigen‐specific blocking of CD4‐Specific immunological synapse formation using BPI and current therapies for autoimmune diseases

  2012cites this paper
• Changes in microarchitectural characteristics at the tibial epiphysis induced by collagen-induced rheumatoid arthritis over time

  2012cites this paper
• Oral tolerance to food protein

  2012cites this paper
• New Therapeutic Challenges in Autoimmune Diseases

  2012cites this paper
• Oral tolerance induction in humans.

  2012cites this paper
• Clinical potential of antigen-specific therapies in type 1 diabetes.

  2012cites this paper
• Modified Glycopeptides Targeting Rheumatoid Arthritis : Exploring molecular interactions in class II MHC/glycopeptide/T-cell receptor complexes

  2011influential citation
• Oral tolerance

  2011cites this paper
• Cellular and Molecular Mechanisms in the Two Major Forms of Inflammatory Bowel Disease

  2011cites this paper
• Potential Health Benefits of n-3 and -6 Fatty Acids in Selected Plant Seed Oils in Rheumatoid Arthritis

  2011cites this paper
• ゲル状嚥下食品“煮こごり”の調理性および抗酸化性の研究

  2011cites this paper
• Absorption and effectiveness of orally administered low molecular weight collagen hydrolysate in rats.

  2010cites this paper
• Suppression of EAE by oral tolerance is independent of endogenous IFN‐β whereas treatment with recombinant IFN‐β ameliorates EAE

  2010cites this paper
• Treating arthritis by immunomodulation: is there a role for regulatory T cells?

  2010cites this paper
• Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis

  2010cites this paper
• New therapies in development for autoimmune diseases: their rationale for combination treatment

  2009cites this paper
• Induction of Tolerance by Oral Administration of Beta-Tubulin in an Animal Model of Autoimmune Inner Ear Disease

  2009cites this paper